Newsletter
Every new paper in this field, in your inbox.
A single-center study on resected gastroesophageal junction adenocarcinoma showed improved operative outcomes over time, with type I tumors linked to poorer survival. Most patients received neoadjuvant therapy and underwent minimally invasive surgery, resulting in low mortality rates and decreased morbidity. Signet ring tumors were more…
Utilizing mediastinal drains alone post-esophageal cancer surgery is safe and reduces postoperative pain. It can potentially replace closed thoracic drains, showing comparable results in terms of hyperthermia, leukocytes, drainage, hospitalization, and pulmonary complications. Early detection of abnormal drainage fluid is a significant benefit, with no…
Endoscopic resection is a safe and effective method for treating intermediate- or high-risk gastric small gastrointestinal stromal tumors, with a 5-year overall survival rate of 97.4%. Close follow-up is necessary for these patients, but there were no recurrences or metastases observed, even among those with…
A scoring system based on seven significant independent prognostic factors, including age, comorbidity, gastrectomy type, complications, cancer stage, and resection status, was developed and validated to predict 1-year mortality in patients with gastric cancer undergoing gastrectomy. This system demonstrated high sensitivity and specificity, aiding in…
Esophageal pull-down technique significantly improves outcomes in end-stage achalasia compared to classical laparoscopic Heller-Dor myotomy. Treatment failure rates were significantly lower in the pull-down technique group, confirming its efficacy in challenging cases. This technique shows promise in enhancing treatment success for difficult-to-treat achalasia patients with…
A multicenter retrospective study evaluated the benefits of repeating esophagogastroduodenoscopy (EGD) at specialized esophagogastric cancer (EGC) centers in Denmark before gastric and esophageal cancer surgery. Among 953 patients who underwent both initial EGD and EGD at referral to a specialized center, 644 cases (68%) lacked…
Fluorodeoxyglucose positron emission tomography (FDG-PET) effectively predicts lymph node status and prognosis in patients with esophageal squamous cell carcinoma (ESCC) undergoing esophagectomy after neoadjuvant chemotherapy (NCT). Researchers reviewed data from 124 ESCC patients and found that FDG-PET pre- and post-NCT correlated significantly with pathological lymph…
A meta-analysis of 16 randomized controlled trials with 1,641 patients assessed the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) for treating and preventing peritoneal carcinomatosis in advanced gastric cancer. Surgery plus HIPEC improved overall survival in both prophylactic (HR 0.56) and therapeutic (HR 0.57) settings, with…
A combined model integrating clinical and contrast-enhanced computed tomography (CE-CT) features accurately predicts specific genetic mutations in gastrointestinal stromal tumors (GISTs). Researchers developed three models from data from 231 GIST patients, with the best model achieving high accuracy in predicting molecular subtypes. In the training…
Endoscopic ultrasonography (EUS) offers 85.3% accuracy in detecting lymph node metastasis in early gastric cancer. A risk score model based on preoperative factors, such as tumor size, lymph nodes, and BMI, provides guidance for treatment selection, despite low sensitivity and PPV. This tool aids clinicians…
